Main Content

Publications 2009


  1. Arolt V, Zwanzger P, Ströhle A, Hamm A, Gerlach A, Kircher T, Deckert J. Das Forschungsnetzwerk PANIC-NET - Von einem besseren Verständnis neurobiologischer Mechanismen der Furchtregulation zu effektiverer psychotherapeutischer Behandlung in der Praxis. Psychotherapie Psychosomatik Medizinische Psychologie 2009, Sonderheft 59 (3-4):124-131.
  2. Beste C, Konrad C, Saft C, Ukas T, Andrich J, Pfleiderer B, Hausmann M, Falkenstein M. Alterations in voluntary movement execution in Huntington's disease are related to the dominant motor system - evidence from event-related potentials. Experimental Neurology 2009, 216:148-157.
  3. Burgmer M, Gaubitz M, Konrad C, Wrenger M, Hilgart S, Heuft G, Pfleiderer B. Decreased Gray Matter Volumes in the Cingulo-Frontal Cortex and the Amygdala in Patients With Fibromyalgia. Psychosomatic Medicine 2009, 71:566-573.
  4. Dannlowski U, Ohrmann P, Konrad C, Bauer J, Kugel H, Hohoff C, Schöning S, Kersting A, Baune BT, Deckert J, Arolt V, Zwitserlood P, Domschke K, Heindel W, Suslow T. Reduced amygdala-prefrontal connectivity in major depression - association with MAOA genotype and symptom severity. International Journal of Neuropsychopharmacology 2009, 12:11-22.
  5. Derntl B, Finkelmeyer A, Toygar TK, Hülsmann A, Schneider F, Falkenberg DI, Habel U. Generalized deficit in all core components of empathy in schizophrenia. Schizophrenia Research 2009, 108:197-206.
  6. Forkmann T, Boeker M, Norra C, Eberle N, Kircher T, Schauerte P, Mischke K, Westhofen M, Gauggel S, Wirtz M. Development of an item bank for the assessment of depression in persons with mental illnesses and physical diseases using Rasch analysis. Rehabilitation Psychology 2009, 54:186-197.
  7. Forkmann T, Boecker M, Wirtz M, Eberle N, Westhofen M, Schauerte P, Mischke K, Kircher T, Gauggel S, Norra C. Development and Validation of the Rasch-based Depression Screening (DESC) using Rasch Analysis and Structural Equation Modelling. Journal of Behavior Therapy and Experimental Psychiatry 2009, 40:468-478.
  8. Freitag CM, Luders E, Hulst HE, Narr KL, Thompson PM, Toga AW, Krick C, Konrad C. Total brain volume and corpus callosum size in medication naive adolescents and young adults with autism spectrum disorder. Biological Psychiatry 2009, 66:316-319.
  9. Gebhardt S, Haberhausen M, Heinzel-Gutenbrunner M, Gebhardt N, Remschmidt H, Krieg JC, Hebebrand J, Theisen FM. Antipsychotic-induced body weight again: predictors and a systematic categorization of the long-term weight course. Journal of Psychiatric Research 2009, 43:620-626.
  10. Gloster AT, Wittchen HU, Einsle F, Höfler M, Lang T, Helbig-Lang S, Fydrich T, Fehm L, Hamm AO, Richter J, Alpers GW, Gerlach AL, Ströhle A, Kircher T, Deckert J, Zwanzger P, Arolt V. Mechanism of Action in CBT (MAC): Methods of a Multi-Center Radomized Controlled Trial in 369 Patients with Panic Disorder and Agoraphobia. European Archives of Psychiatry and Clinical Neuroscience 2009, 259 Suppl 2:S155-166.
  11. Green A, Straube B, Weis S, Jansen A, Willmes K, Konrad K, Kircher T. Neural integration of iconic and unrelated coverbal gestures: A functional MRI study. Human Brain Mapping 2009, 30:3309-3324.
  12. Hemmeter UM, Thum A. Treatment of insomnia. Therapeutische Umschau 2009, 66:441-448.
  13. Jansen A, Krach S, Krug A, Markov V, Eggermann T, Zerres K, Stöcker T, Shah NJ, Nöthen MM, Treutlein J, Rietschel M, Kircher T. A putative high risk diplotype of the G72 gene is in healthy individuals associated with better performance in working memory functions and altered brain activity in the medial temporal lobe. Neuroimage 2009, 45:1002-1008.
  14. Jansen A, Krach S, Krug A, Markov V, Eggermann T, Zerres K, Thimm M, Nothen M, Treutlein J, Rietschel M, Kircher T. Effect of the G72 (DAOA) putative risk haplotype on cognitive functions in healthy subjects. BMC Psychiatry 2009, 9:60.
  15. Jansen A, Sehlmeyer C, Pfleiderer B, Sommer J, Konrad C, Zwitserlood P, Knecht S. Assessment of Verbal Memory by FMRI: Lateralization and Functional Neuroanatomy. Clinical Neurology Neurosurgery 2009, Suppl. 111:57-62.
  16. Kircher T, Blümel I, Marjoram D, Lataster T, Krabbendam L, Weber J, van Os J, Krach S. Online mentalising investigated with functional MRI. Neuroscience Letters 2009, 454:176-181.
  17. Kircher T, Krug A, Markov V, Whitney C, Krach S, Zerres K, Eggermann T, Stöcker T, Shah NJ, Treutlein J, Nöthen MM, Becker T, Rietschel M. Genetic variation in the schizophrenia-risk gene neuregulin 1 correlates with brain activation and impaired speech production in a verbal fluency task in healthy individuals. Human Brain Mapping 2009, 30:3406-3416.
  18. Kircher T, Leube D, Habel U. Funktionelle MRT bei Patienten mit Schizophrenie: Neurale Korrelate von Symptomen, Kognition und Emotion. Der Nervenarzt 2009, 80:1103-1116.
  19. Kircher T, Markov V, Krug A, Eggermann T, Zerres K, Nöthen MM, Skowronek MH, Rietschel M. Association of the DTNBP1 genotype with cognition and personality traits in healthy subjects. Psychological Medicine 2009, 39:1657-1665.
  20. Kircher T, Sass K, Sachs O, Krach S. Priming words with pictures: Neural correlates of semantic associations in a cross-modal priming task using fMRI. Human Brain Mapping 2009, 30:4116-4128.
  21. Kircher T, Straube B, Leube D, Weis S, Sachs O, Willmes K, Konrad K, Green A. Neural interaction of speech and gesture: Differential activations of metaphoric coverbal gestures. Neuropsychologia 2009, 47:169-179.
  22. Kircher T, Thienel R, Wagner M, Reske M, Habel U, Kellermann T, Frommann I, Schwab S, Wölwer W, von Wilmsdorf M, Braus DF, Schmitt A, Rapp A, Stöcker T, Shah NJ, Henn FA, Sauer H, Gaebel W, Maier W, Schneider F. Neuregulin 1 ICE-Single Nucleotide Polymorphism in First Episode Schizophrenia Correlates with Cerebral Activation in Fronto-Temporal Areas. European Archives of Psychiatry and Clinical Neurosciences 2009, 259:72-79.
  23. Klingberg S, Wittorf A, Bechdolf A, Herrlich J, Kircher T, König HH, Müller B, Sartory G, Wagner M, Wiedemann G, Wölwer W, Buchkremer G. Research into the feasibility of cognitive behavioural therapy in the treatment of psychotic disorders. Psychotherapie Psychosomatik Medizinische Psychologie 2009, 59:141-148.
  24. Konrad C, Ukas T, Nebel C, Arolt V, Toga AW, Narr KL. Defining the human hippocampus in cerebral magnetic resonance images - An overview of current segmentation protocols. Neuroimage 2009, 47:1185-1195.
  25. Krach S, Blümel I, Majoram D, Lataster T, Krabbendam L, Weber J, van Os J, Kircher T. Are women better mindreaders? Sex differences in neural correlates of mentalizing detected with functional MRI. BMC Neuroscience 2009, 10:9.
  26. Krug A, Markov V, Sheldrick A, Krach S, Jansen A, Zerres K, Eggermann T, Stöcker T, Shah NJ, Kircher T. The effect of the COMT val(158)met polymorphism on neural correlates of semantic verbal fluency. European Archives of Psychiatry Clinical Neuroscience 2009, 259:459-465.
  27. Kundermann B, Hemmeter-Spernal J, Strate P, Gebhardt S, Huber MT, Krieg JC, Lautenbacher S. Pain sensitivity in major depression and its relationship to central serotoninergic function as reflected by the neuroendocrine response to clomipramine. Journal of Psychiatric Research 2009, 43:1253-1261.
  28. Kundermann B, Strate P, Hemmeter-Spernal J, Huber MT, Krieg JC, Lautenbacher S. Mid-term effects of serial sleep deprivation therapy implemented in cognitive-behavioral treatment on the neuroendocrine response to clomipramine in patients with major depression. Journal of Psychiatric Research 2009, 43:711-720.
  29. Kunz M, Mylius V, Scharmann S, Schepelmann K, Lautenbacher S. Influence of dementia on multiple components of pain. European Journal of Pain 2009, 13:317-325.
  30. Kunz M, Mylius V, Schepelmann K, Lautenbacher S. Effects of age and mild cognitive impairment on the pain response system. Gerontology 2009, 55:674-682.
  31. Le Hellard S, Theisen FM, Haberhausen M, Raeder MB, Ferno J, Gebhardt S, Hinney A, Remschmidt H, Krieg JC, Mehler-Wex C, Nöthen MM, Hebebrand J, Steen VM. Association between the insulin-induced gene 2 (INSIG2) and weight gain in a German sample of antipsychotic-treated schizophrenic patients: perturbation of SREBP-controlled lipogenesis in drug-related metabolic adverse effects? Molecular Psychiatry 2009, 14:308-317.
  32. Leube D, Kircher T. Gedächtnis und MCI: Eine differenzierte Betrachtung der beteiligten Hirnareale ist notwendig. Zeitschrift für Gerontopsychologie und -psychiatrie 2009, (im Druck).
  33. Markov V, Krug A, Krach S, Whitney C, Eggermann T, Zerres K, Stöcker T, Shah NJ, Nöthen MM, Treutlein J, Rietschel M, Kircher T. Genetic variation in schizophrenia-risk-gene dysbindin 1 modulates brain activation in anterior cingulate cortex and right temporal gyrus during language production in healthy individuals. NeuroImage 2009, 47:2016-2022.
  34. Möller JC, Unger M, Stiasny-Kolster K, Kaussner Y, Penzel T, Oertel WH, Hemmeter U. Continuous sleep EEG monitoring in PD patients with and without sleep attacks. Parkinsonism & Related Disorders 2009, 15:238-241.
  35. Nickl-Jockschat T, Kircher T. The 21st European College of Neuropsychopharmacology Congress. Advances in Schizophrenia and Clinical Psychiatry 2009, 4:28-31.
  36. Nickl-Jockschat T, Rietschel M, Kircher T. Correlations between risk gene variants for schizophrenia and brain structure anomalies. Der Nervenarzt 2009, 80:40-42, 44-46.
  37. Pyka M, Beckmann C, Schöning S, Hauke S, Heider D, Kugel H, Arolt V, Konrad C. Impact of Working Memory Load on fMRI Resting State Pattern in subsequent Resting Phases. PLoS One 2009, 4(9):e7198.
  38. Reinhardt I, Jansen A, Kircher T. Neurofunktionelle Bildgebung bei Angststörungen. Verhaltenstherapie 2009, 19:78-85.
  39. Sass K, Krach S, Sachs O, Kircher T. Lion-Tiger-Stripes: Neural correlates of indirect semantic priming across processing modalities. NeuroImage 2009, 45:224-236.
  40. Sass K, Sachs K, Krach S, Kircher T. Taxonomic and thematic categories: Neural correlates of categorization in an auditory-to-visual priming task using fMRI. Brain Research 2009, 1270:78-87.
  41. Schlotterbeck P, Saur R, Hiemke C, Gründer G, Vehren T, Kircher T, Leube D. Low concentration of ziprasidone in human milk: a case report. International Journal of Neuropsychopharmacology 2009, 12:437-438.
  42. Schmidt AJ, Hemmeter UM, Krieg JC, Vedder H, Heiser P. Impact of haloperidol an quetiapine on the expression of genes encoding antioxidant enzymes in human neuroblastoma SH-SY5Y cells. Journal of Psychiatric Research 2009, 43:818-823.
  43. Schöning S, Zwitserlood P, Engelien A, Behnken A, Kugel H, Dannlowski U, Schiffbauer H, Lipina K, Pachur C, Kersting A, Baune BT, Zwanzger P, Reker T, Heindel W, Arolt V, Konrad C. Working-Memory fMRI Reveals Cingulate Hyperactivation in Euthymic Major Depression. Human Brain Mapping 2009, 30:2746-2756.
  44. Sehlmeyer C, Schöning S, Zwitserlood P, Pfleiderer B, Kircher T, Arolt V, Konrad C. Human Fear Conditioning and Extinction in Neuroimaging: A Review. PLoS ONE 2009, 4:e5865.
  45. Seiferth NY, Pauly K, Kellermann T, Shah NJ, Ott G, Herpertz-Dahlmann B, Kircher T, Schneider F, Habel U. Neuronal correlates of facial emotion discrimination in early-onset schizophrenia. Neuropsychopharmacology 2009, 34:477-487.
  46. Spreckelmeyer K, Krach S, Kohls G, Rademacher L, Irmak A, Konrad K, Kircher T, Gründer G. Anticipation of monetary and social reward differently activates mesolimbic brain structures in men and women. Social Cognitive and Affective Neuroscience 2009, 4:158-165.
  47. Straube B, Green A, Weis S, Chatterjee A, Kircher T. Memory effects of speech and gesture binding: Cortical and hippocampal activation in relation to subsequent memory performance. Journal of Cognitive Neuroscience 2009, 21:821-836.
  48. Suslow T, Kugel H, Rauch AV, Dannlowski U, Bauer J, Konrad C, Arolt V, Heindel W, Ohrmann P. Attachment avoidance modulates neural response to masked facial emotion. Human Brain Mapping 2009, 30:3553-3562.
  49. Thienel R, Kellermann T, Schall U, Voss B, Reske M, Halfter S, Sheldrick A, Radenbach K, Habel U, Shah NJ, Kircher T. Muscarinic antagonist effects on executive function of attention. International Journal of Neuropsychopharmacology 2009, 12:1307-1317.
  50. Thienel R, Voss B, Kellermann T, Reske M, Halfter S, Sheldrick A, Radenbach K, Habel U, Shah NJ, Schall U, Kircher T. Nicotinic antagonist effects on functional attention networks. International Journal of Neuropsychopharmacology 2010, 12:1295-1305.
  51. Whitney C, Huber W, Klann J, Weis S, Krach S, Kircher T. Neural correlates of narrative shifts during auditory story comprehension. Neuroimage 2009, 47:360-366.
  52. Whitney C, Grossmann, Kircher T. The influence of multiple primes on bottom-up and top-down regulation during meaning retrieval: evidence for two distinct neural networks. Cerebral Cortex 2010, 19:2548-2560.
  53. Whitney C, Weis S, Krings T, Huber W, Kircher T. Task-dependent modulations of prefrontal and hippocampal activity during intrinsic word production. Journal of Cognitive Neuroscience 2009, 21:697-712.

Book Chapters

  1. Hemmeter U. State of the art - treatment of cognitive, behavioral and psychopathalogical symptoms of Alzheimer's disease. In: Bährer-Kohler (Hrsg.) Self Management of Chronic Disease. (S. 47-56). Springer Medizin Verlag, Heidelberg 2009
  2. Whitney C, Kircher T. Language lateralization in patients with formal thought disorder. In: Sommer IEC, Kahn RE. (Hrsg) Language Lateralization and Psychosis. (S. 169-180) Cambridge University Press, Cambridge, 2009